13D Filing: Orbimed Israel Biofund GP Limited Partnership and Novus Therapeutics Inc. (NVUS)

Page 7 of 9 – SEC Filing

SIGNATURE
After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated:  May 19, 2017
ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP
By:
OrbiMed Israel GP Ltd., its General Partner
By:
 /s/ Nissim Darvish
Nissim Darvish
Director
ORBIMED ISRAEL GP LTD.
By:
 /s/ Nissim Darvish
Nissim Darvish
Director

Follow Eledon Pharmaceuticals Inc. (NASDAQ:ELDN)